Published in Int J Mol Sci on April 17, 2014
Association between dietary calcium and phosphorus intakes, dietary calcium/phosphorus ratio and bone mass in the Korean population. Nutr J (2014) 0.79
Longitudinal associations of nutritional factors with glycated hemoglobin in youth with type 1 diabetes: the SEARCH Nutrition Ancillary Study. Am J Clin Nutr (2015) 0.78
Diabetes mellitus in elderly. Indian J Endocrinol Metab (2015) 0.77
Influence of obesity on vertebral fracture prevalence and vitamin D status in postmenopausal women. Nutr Metab (Lond) (2015) 0.76
Low serum vitamin D-status, air pollution and obesity: A dangerous liaison. Rev Endocr Metab Disord (2017) 0.76
Association between Obesity and Serum 25(OH)D Concentrations in Older Mexican Adults. Nutrients (2017) 0.75
The relationship between vitamin D status, physical activity and insulin resistance in overweight and obese subjects. Bosn J Basic Med Sci (2015) 0.75
Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women. Arch Osteoporos (2017) 0.75
Relationship between vitamin D and glycemic control in patients with type 2 diabetes mellitus. Int J Clin Exp Med (2015) 0.75
Mini-Review: The Contribution of Intermediate Phenotypes to GxE Effects on Disorders of Body Composition in the New OMICS Era. Int J Environ Res Public Health (2017) 0.75
Vitamin D deficiency. N Engl J Med (2007) 59.34
Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2011) 23.10
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA (2010) 11.59
Endocrine regulation of energy metabolism by the skeleton. Cell (2007) 10.41
The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab (2007) 8.91
A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med (2012) 6.85
Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab (2005) 5.64
Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med (2010) 5.36
Vitamin D physiology. Prog Biophys Mol Biol (2006) 4.13
Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ (2005) 4.04
Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol (2007) 3.49
Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int (2008) 3.48
Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med (2004) 3.45
Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab (2005) 3.36
Vitamin D: modulator of the immune system. Curr Opin Pharmacol (2010) 3.31
Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer (2003) 2.82
Effect of annual intramuscular vitamin D on fracture risk in elderly men and women--a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) (2007) 2.81
Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care (2008) 2.76
Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest (2007) 2.73
Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med (2013) 2.73
Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med (2005) 2.72
Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr (2009) 2.71
The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev (2012) 2.71
Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J (2000) 2.57
Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab (2007) 2.55
A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med (2009) 2.46
Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab (2012) 2.41
Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology (2006) 2.40
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev (2010) 2.38
Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J Am Geriatr Soc (2005) 2.38
African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox. Am J Clin Nutr (2008) 2.37
1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol (2009) 2.22
Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol (2010) 2.16
Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res (2003) 2.15
Molecular mechanisms of vitamin D action. Calcif Tissue Int (2012) 2.06
Vitamin D(3) in fat tissue. Endocrine (2008) 2.02
Calcium metabolism in health and disease. Clin J Am Soc Nephrol (2010) 2.01
Serum 25-hydroxyvitamin d levels and prediabetes among subjects free of diabetes. Diabetes Care (2011) 1.96
Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol (2004) 1.89
Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol (2011) 1.84
Effect of vitamin D(3) and calcium on fracture risk in 65- to 71-year-old women: a population-based 3-year randomized, controlled trial--the OSTPRE-FPS. J Bone Miner Res (2010) 1.81
Bone as an endocrine organ. Trends Endocrinol Metab (2009) 1.75
Benefit-risk assessment of vitamin D supplementation. Osteoporos Int (2009) 1.70
Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab (2009) 1.64
Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr (2007) 1.61
Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol (2003) 1.60
Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome. Diabetes Care (2010) 1.59
The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass--a randomized controlled 1-year trial. Osteoporos Int (2011) 1.58
Factors influencing vitamin D status. Acta Derm Venereol (2011) 1.56
Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocrinol Metab (2007) 1.51
A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NONOF) Study. Age Ageing (2004) 1.50
25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring) (2010) 1.50
Vitamin D status, adiposity, and lipids in black American and Caucasian children. J Clin Endocrinol Metab (2011) 1.49
Where is the vitamin D receptor? Arch Biochem Biophys (2012) 1.45
Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ (2010) 1.45
Vitamin D status among patients with hip fracture and elderly control subjects in Yekaterinburg, Russia. Osteoporos Int (2005) 1.42
Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromsø study. Eur J Nutr (2010) 1.40
Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3). Cell Biochem Funct (2002) 1.40
The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor. J Mol Biol (2005) 1.39
Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. J Bone Miner Res (2009) 1.38
Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol (2008) 1.32
Vitamin D and diabetes: its importance for beta cell and immune function. Mol Cell Endocrinol (2011) 1.30
Vitamin D signalling in adipose tissue. Br J Nutr (2012) 1.28
What is the role of serial bone mineral density measurements in patient management? J Clin Densitom (2002) 1.25
Vitamin D deficiency as a risk factor for osteoporotic fractures. Bone (2007) 1.24
Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr (2011) 1.22
The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab (2011) 1.22
1Alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine (2009) 1.20
Vitamin d deficiency in Saudi Arabs. Horm Metab Res (2010) 1.16
Calcium and vitamin D supplementation is associated with decreased abdominal visceral adipose tissue in overweight and obese adults. Am J Clin Nutr (2011) 1.14
Serum 25-hydroxyvitamin D is not associated with insulin resistance or beta cell function in Canadian Cree. J Nutr (2010) 1.13
Effects of calcium and vitamin D supplementation on hip bone mineral density and calcium-related analytes in elderly ambulatory Australian women: a five-year randomized controlled trial. J Clin Endocrinol Metab (2007) 1.12
The bone-adipose axis in obesity and weight loss. Obes Surg (2008) 1.11
Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial. Breast Cancer Res Treat (2011) 1.10
Is obesity in women protective against osteoporosis? Diabetes Metab Syndr Obes (2011) 1.09
Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation. Osteoporos Int (2007) 1.09
The role of vitamin D for bone health and fracture prevention. Curr Osteoporos Rep (2006) 1.07
UK Food Standards Agency Workshop Report: an investigation of the relative contributions of diet and sunlight to vitamin D status. Br J Nutr (2010) 1.05
The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts. J Steroid Biochem Mol Biol (2010) 1.01
Vitamin D deficiency before bariatric surgery: should supplement intake be routinely prescribed? Obes Surg (2011) 1.00
Mechanistic roles for calcium and vitamin D in the regulation of body weight. Obes Rev (2012) 0.99
The effects of a 30-month dietary intervention on bone mineral density: the Postmenopausal Health Study. Br J Nutr (2010) 0.97
Relations between obesity, insulin resistance, and 25-hydroxyvitamin D. Am J Clin Nutr (2012) 0.96
The effect of calcium and vitamin D supplementation on obesity in postmenopausal women: secondary analysis for a large-scale, placebo controlled, double-blind, 4-year longitudinal clinical trial. Nutr Metab (Lond) (2010) 0.96
No significant effect on bone mineral density by high doses of vitamin D3 given to overweight subjects for one year. Nutr J (2010) 0.96
The effects of whole-body vibration training and vitamin D supplementation on muscle strength, muscle mass, and bone density in institutionalized elderly women: a 6-month randomized, controlled trial. J Bone Miner Res (2011) 0.93
Low vitamin D levels in Northern American adults with the metabolic syndrome. Horm Metab Res (2010) 0.93
VDR haploinsufficiency impacts body composition and skeletal acquisition in a gender-specific manner. Calcif Tissue Int (2011) 0.92
Vitamin D activation of functionally distinct regulatory miRNAs in primary human osteoblasts. J Bone Miner Res (2013) 0.91
Vitamin D status in Norwegian children and adolescents with excess body weight. Pediatr Diabetes (2010) 0.89
Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: a 1-year double-blind RCT in postmenopausal women. J Bone Miner Res (2013) 0.88
Hypovitaminosis D as a risk factor of hip fracture severity. Osteoporos Int (2011) 0.88
Effect of oral cholecalciferol 2,000 versus 5,000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency. Osteoporos Int (2012) 0.87
Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65-71 years: a 3-year randomized population-based trial (OSTPRE-FPS). Osteoporos Int (2010) 0.86
Can vitamin D supplementation prevent bone loss in persons with MS? A placebo-controlled trial. J Neurol (2011) 0.85
Vitamin D deficiency and insulin resistance in obese African-American adolescents. J Pediatr Endocrinol Metab (2011) 0.84